Molecular interactions leading to lipoprotein retention and the initiation of atherosclerosis
- PMID: 15472124
- DOI: 10.1161/01.ATV.0000147163.54024.70
Molecular interactions leading to lipoprotein retention and the initiation of atherosclerosis
Abstract
Atherosclerosis is distinguished by the accumulation of lipoprotein lipid within the arterial wall. An ionic interaction of positively charged regions of apolipoprotein (apo) B with matrix proteins, including proteoglycans, collagen, and fibronectin, is thought to initiate this process. Proteoglycans are complex glycoproteins containing highly negatively charged carbohydrate chains. These proteins are abundant in atherosclerosis lesions, and they associate with apoB-containing lipoproteins. Several specific regions of apoB may mediate this process. Other lipoprotein-associated proteins, including apoE and lipases, might also participate in this process. In addition, retention may occur via lipoprotein association with other matrix molecules or as a consequence of intra-arterial lipoprotein aggregation.
Similar articles
-
Subendothelial retention of atherogenic lipoproteins in early atherosclerosis.Nature. 2002 Jun 13;417(6890):750-4. doi: 10.1038/nature00804. Nature. 2002. PMID: 12066187
-
Serum amyloid A and lipoprotein retention in murine models of atherosclerosis.Arterioscler Thromb Vasc Biol. 2005 Apr;25(4):785-90. doi: 10.1161/01.ATV.0000158383.65277.2b. Epub 2005 Feb 3. Arterioscler Thromb Vasc Biol. 2005. PMID: 15692094
-
Lipoprotein-matrix interactions in macrovascular disease in diabetes.Front Biosci. 2004 May 1;9:1728-42. doi: 10.2741/1248. Front Biosci. 2004. PMID: 14977582 Review.
-
Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications.Circulation. 2007 Oct 16;116(16):1832-44. doi: 10.1161/CIRCULATIONAHA.106.676890. Circulation. 2007. PMID: 17938300 Review.
-
Retention of low-density lipoprotein in atherosclerotic lesions of the mouse: evidence for a role of lipoprotein lipase.Circ Res. 2007 Oct 12;101(8):777-83. doi: 10.1161/CIRCRESAHA.107.149666. Epub 2007 Aug 30. Circ Res. 2007. PMID: 17761930
Cited by
-
The Initial Human Atherosclerotic Lesion and Lipoprotein Modification-A Deep Connection.Int J Mol Sci. 2021 Oct 25;22(21):11488. doi: 10.3390/ijms222111488. Int J Mol Sci. 2021. PMID: 34768918 Free PMC article. Review.
-
Lipoprotein lipase inhibits hepatitis C virus (HCV) infection by blocking virus cell entry.PLoS One. 2011;6(10):e26637. doi: 10.1371/journal.pone.0026637. Epub 2011 Oct 21. PLoS One. 2011. PMID: 22039521 Free PMC article.
-
Advanced glycation endproduct changes to Bruch's membrane promotes lipoprotein retention by lipoprotein lipase.Am J Pathol. 2011 Aug;179(2):850-9. doi: 10.1016/j.ajpath.2011.04.010. Epub 2011 Jun 12. Am J Pathol. 2011. PMID: 21801873 Free PMC article.
-
Contribution of macromolecular structure to the retention of low-density lipoprotein at arterial branch points.Circulation. 2008 Jun 3;117(22):2919-27. doi: 10.1161/CIRCULATIONAHA.107.754614. Epub 2008 May 27. Circulation. 2008. PMID: 18506002 Free PMC article.
-
The Chemical Inhibitors of Endocytosis: From Mechanisms to Potential Clinical Applications.Cells. 2023 Sep 19;12(18):2312. doi: 10.3390/cells12182312. Cells. 2023. PMID: 37759535 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous